You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 466 Use of a 27-gene immuno-oncology (IO) assay to associate response to single-agent immune checkpoint inhibitor (ICI) therapy in advanced-stage NSCLC patients from a large Canadian cohort

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
466 Use of a 27-gene immuno-oncology (IO) assay to associate response to single-agent immune checkpoint inhibitor (ICI) therapy in advanced-stage NSCLC patients from a large Canadian cohort
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to November 2024

AbstractFullPdf
Nov 202119609
Dec 202146013
Jan 20221806
Feb 20224207
Mar 202216808
Apr 20226406
May 202248014
Jun 20221805
Jul 20223203
Aug 20221604
Sep 20222806
Oct 20223006
Nov 20224005
Dec 20223206
Jan 20233405
Feb 20233001
Mar 20232601
Apr 20232003
May 2023804
Jun 2023601
Jul 20231208
Aug 20231004
Sep 20231603
Oct 2023601
Nov 20231804
Dec 20233402
Jan 20242001
Feb 20243803
Mar 202412035
Apr 2024603
May 20241605
Jun 20241001
Jul 20242403
Aug 20241002
Sep 20241805
Oct 20241607
Nov 2024602
Total11740202